Global Preclinical CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Preclinical CRO Market is presumed to reach the market size of nearly USD 20.98 BN by 2030 from USD 9.09 BN in 2022 with a CAGR of 11.02% under the study period 2023 - 2030.

A preclinical CRO, or contract research organization, is a company that provides research and testing services to industries mainly in the field of pharmaceutical, biotechnology, and medical devices. These services are typically conducted during the preclinical stage of drug development, which refers to the period before a new drug is tested in human clinical trials. Preclinical CRO services can include a wide range of activities, such as laboratory testing, animal testing, and toxicology studies. Preclinical CRO companies typically have specialized laboratories and equipment and highly trained staff with expertise in various scientific fields.

Market Dynamics:

The increasing regulatory requirements for new drugs and medical devices are expected to raise the market. The development of a new drug is a long, expensive process that requires significant resources and expertise. Pharma, biotech, and medical device manufacturers often find it more cost-effective to outsource certain aspects of their research and development efforts to specialized CROs, which may drive market growth.Moreover, the increasing demand for new drugs and medical treatments boosts market growth. These companies play a vital role in developing new medicines and medical devices, assisting in ensuring the safety and effectiveness of the medicine before it is available to the public. However, the use of animals in the research and development process may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of preclinical cro. The growth and trends of preclinical cro industry provide a holistic approach to this study.

Market Segmentation:

This section of the preclinical cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

Bioanalysis And Dmpk Studies (In Vitro ADME, In-Vivo PK)
Toxicology Testing (GLP, Non-GLP)
Compound Management (Process R&D, Custom Synthesis, Others)
Chemistry (Medicinal Chemistry, Computation Chemistry)
Safety Pharmacology
Others

By Model Type

Patient Derived Organoid (PDO) Model
Patient Derived Xenograft Model

By End-Use

Biopharmaceutical Companies
Government And Academic Institutes
Medical Device Companies

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Preclinical CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the preclinical cro market include SGS SA (SGS), Charles River Laboratories International Inc., Eurofins Scientific, PRA Health Sciences Inc., Wuxi AppTec, Medpace Inc., Pharmaceutical Product Development (PPD) LLC, Intertek Group Plc (IGP), Crown Bioscience and Laboratory Corporation of America Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

Product Code: VMR112110008

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PRECLINICAL CRO - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Service
- 3.7.2 Market Attractiveness Analysis By Model Type
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PRECLINICAL CRO MARKET ANALYSIS BY SERVICE

6.1 Overview by Service
6.2 Historical and Forecast Data
6.3 Analysis by Service
6.4 Bioanalysis and DMPK studies (In vitro ADME, In-vivo PK) Historic and Forecast Sales by Regions
6.5 Toxicology Testing (GLP, Non-GLP) Historic and Forecast Sales by Regions
6.6 Compound Management (Process R&D, Custom Synthesis, Others) Historic and Forecast Sales by Regions
6.7 Chemistry (Medicinal Chemistry, Computation Chemistry) Historic and Forecast Sales by Regions
6.8 Safety Pharmacology Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL PRECLINICAL CRO MARKET ANALYSIS BY MODEL TYPE

7.1 Overview by Model Type
7.2 Historical and Forecast Data
7.3 Analysis by Model Type
7.4 Patient Derived Organoid (PDO) Model Historic and Forecast Sales by Regions
7.5 Patient Derived Xenograft Model Historic and Forecast Sales by Regions

8 . GLOBAL PRECLINICAL CRO MARKET SALES ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Biopharmaceutical Companies Historic and Forecast Sales by Regions
8.5 Government And Academic Institutes Historic and Forecast Sales by Regions
8.6 Medical Device Companies Historic and Forecast Sales by Regions

9 . GLOBAL PRECLINICAL CRO MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PRECLINICAL CRO COMPANIES

10.1. Preclinical Cro Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF PRECLINICAL CRO INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. SGS SA (SGS)
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Charles River Laboratories International Inc.
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Eurofins Scientific
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. PRA Health Sciences Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Wuxi AppTec
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Medpace Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Pharmaceutical Product Development (PPD) LLC
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Intertek Group Plc (IGP)
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Crown Bioscience and Laboratory Corporation of America Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies